Insider · CIK 0002108976
Gevorg Grigoryan
Files at GENB (Generate Biomedicines, Inc.). First filing -, latest -.
In brief
Gevorg Grigoryan files SEC Form 4 as officer at GENB (Generate Biomedicines, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gevorg Grigoryan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +295,608 | $0.00 | $0 | 295,608 | Mar 2, 2026 |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +196,368 | $0.00 | $0 | 196,368 | Mar 2, 2026 |
Questions about Gevorg Grigoryan
Answered from the filings on this page, as of the latest one.
Is Gevorg Grigoryan buying or selling?
Gevorg Grigoryan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gevorg Grigoryan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gevorg Grigoryan has 0.
Where does Gevorg Grigoryan file Form 4?
Gevorg Grigoryan has filed Form 4 at GENB (Generate Biomedicines, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.